Cerebral ischemia
Pro Research Analysisby 
Searched over 200M research papers for "cerebral ischemia"
Pathophysiology of Cerebral Ischemia: Energy Failure, Excitotoxicity, and Cell Death
Cerebral ischemia occurs when blood flow to the brain is reduced or blocked, leading to a shortage of oxygen and nutrients. This triggers a cascade of harmful processes, including energy failure, loss of cell ion balance, acidosis, increased intracellular calcium, excitotoxicity, and damage from free radicals. These processes can cause neurons to die either quickly through necrosis or more slowly through apoptosis, depending on the severity and duration of the ischemia. The core area of an infarct experiences rapid necrotic cell death due to severe energy failure, while surrounding areas (the ischemic penumbra) may be salvageable if blood flow is restored in time. Reperfusion can also introduce new damage by increasing inflammation and free radical production. Changes in gene expression after ischemia may either protect neurons or contribute to further injury, including apoptosis and other detrimental processes Macdonald1998Ahad2020.
Microcirculation, Autoregulation, and the Neurovascular Unit in Ischemic Injury
Disruptions in the brain’s microcirculation and autoregulation play a primary role in the development of cerebral infarction. Thrombus formation, often responsible for about 60% of cerebral ischemia cases, leads to increased permeability of the blood-brain barrier and alters the brain’s microenvironment. This affects the neurovascular unit (NVU), which is essential for brain function. Coagulation factors, especially thrombin, interact with the NVU and may contribute to brain injury during ischemia. Understanding these interactions is important for developing new therapeutic approaches that target coagulation and protect the NVU Díaz1980Cao2021.
Cellular and Metabolic Changes: ATP Decline, Calcium Overload, and Blood-Brain Barrier Breakdown
Cerebral ischemia leads to a decline in adenosine triphosphate (ATP), malfunctioning of the Na+/K+-ATPase pump, calcium overload, excitotoxicity, cytotoxic edema, and breakdown of the blood-brain barrier. These changes result in neuronal cell death, white matter lesions, and hippocampal damage. Metabolomic studies have shown that ischemia causes complex metabolic disturbances, which can be used to identify potential biomarkers and guide the development of new diagnostic and therapeutic strategies Ahad2020Shin2020.
Inflammation, Microglia, and Neuroimmune Interactions
Microglia, the brain’s main immune cells, play a significant role in the response to cerebral ischemia. They interact with neurons and blood vessels, contributing to both acute and delayed brain injury. Neuroinflammation, driven by microglia and other immune responses, is now recognized as a key factor in the progression of ischemic damage. Modulating these microglia-neuron-vascular interactions may offer new therapeutic opportunities in combination with neuroprotective and blood flow restoration strategies .
Delayed Cerebral Ischemia: Beyond Vasospasm to Multifactorial Mechanisms
Delayed cerebral ischemia (DCI), especially after subarachnoid hemorrhage, was once thought to be caused mainly by large artery vasospasm. However, recent research shows that DCI is multifactorial, involving microvascular spasm, microthrombosis, cerebrovascular dysregulation, cortical spreading depolarizations, and neuroinflammation. These mechanisms collectively lead to inflammation and early brain injury. The only proven pharmacological intervention for DCI is nimodipine, a calcium channel blocker, highlighting the need for new therapies that target these diverse mechanisms Geraghty2017Ikram2021.
Therapeutic Strategies and Future Directions
Currently, treatment options for cerebral ischemia are limited. The main effective therapies are anti-thrombolytics (such as tissue plasminogen activator) and hypothermia. Many other pharmacological approaches have not succeeded in reducing neuronal injury or improving outcomes. Research is ongoing into novel therapies, including growth factors, NAD, melatonin, resveratrol, protein kinase C isozymes, pifithrin, fatty acids, sympathoplegic drugs, and stem cells. Understanding the underlying mechanisms of ischemic injury is crucial for developing effective prevention and treatment strategies .
Conclusion
Cerebral ischemia is a complex condition involving energy failure, excitotoxicity, inflammation, and disruption of the neurovascular unit. Both immediate and delayed injuries are driven by a combination of metabolic, cellular, and immune mechanisms. While some treatments exist, there is a pressing need for new therapies that address the multifactorial nature of ischemic brain injury. Ongoing research into the pathophysiology and molecular changes in cerebral ischemia will be key to improving outcomes for affected patients Macdonald1998Ahad2020Lee2018+5 MORE.
Sources and full results
Most relevant research papers on this topic
Pathophysiology of cerebral ischemia.
Cerebral ischemia leads to energy failure, loss of cell ion homeostasis, acidosis, increased intracellular calcium, excitotoxicity, and free radical-mediated toxicity, with potential pharmacological therapies on the horizon.
Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: Beyond Vasospasm and Towards a Multifactorial Pathophysiology
Recent studies suggest that cerebral vasospasm is not the sole contributor to delayed cerebral ischemia after subarachnoid hemorrhage, and other mechanisms play equally or more important roles.
Delayed Cerebral Ischemia after Subarachnoid Hemorrhage.
Newer diagnostic modalities and interventions are needed to effectively diagnose and prevent delayed cerebral ischemia after subarachnoid hemorrhage.
DOI